|
|
 |
SENSEX
|
 |
-437.29
|
-0.61%
|
71588.86
|
|
|
NIFTY
|
 |
-124.60
|
-0.57%
|
21586.20
|
|
|
Nasdaq
|
 |
13.77
|
0.09%
|
14524.07
|
|
|
Nikkei 225
|
 |
89.13
|
0.27%
|
33377.42
|
|
|
FTSE 100
|
 |
-33.50
|
-0.43%
|
7689.60
|
|
|
 |
|
|
|
|
|
YOU ARE ON
Equity
|
|
|
|
|
|
|
|
|
Industry : Pharmaceuticals & Drugs |
House : Cadila |
BSE Code |
532321
|
ISIN Demat |
INE010B01027
|
Book Value (Rs) |
144.26
|
|
NSE Code |
ZYDUSLIFE
|
Dividend Yield % |
0.84
|
Market Cap (Rs) |
722207.65
|
|
TTM PE(x) |
30.96
|
TTM EPS(Rs) |
23.04
|
Face Value(Rs.) |
1
|
|
|
|
|
|
|
Incorporation Year
|
15-05 1995
|
Registered Office
|
Zydus Corporate Park, Scheme No.63,Survey No. 536, Khoraj (Gandhinagar), Nr. Vaishnodevi Circle,Sarkhej - Gandhinagar Highway, Ahmedabad, Gujarat-382481 .
|
ISINNO
|
INE010B01027
|
Phone
|
079-71800000 / 48040000
|
E-mail
|
dhavalsoni@zyduscadila.com |
URL
|
www.zyduscadila.com |
Industry
|
Pharmaceuticals & Drugs
|
Chairman
|
Pankaj R Patel
|
Managing Director
|
Sharvil P Patel
|
Company Secretary
|
Dhaval N Soni
|
Listing
|
BSE,NSE,MCX
|
|
|
|
|
|
|
|
|
|
|
|